Dawn Carter: What Does an Acute Stroke Diagnosis Tell Us, If It Never Shows Up in Hospital Data?
Dawn Carter, Senior Director of Health Policy and Regulatory Affairs at Centauri Health Solutions, shared on LinkedIn:
”What does an acute stroke diagnosis tell us… if it never shows up in hospital data?
A recent OIG audit underscores a critical disconnect between clinical reality and data interoperability.
According to AAPC guidance, which was specifically mentioned in the report, acute stroke diagnoses should only be assigned during an acute encounter and confirmed in a hospital setting (ER or inpatient).
Yet OIG found that none of the sampled cases with acute stroke codes on physician claims had a corresponding hospital-based diagnosis in the same service year.
This isn’t just a coding issue; it’s a data architecture issue.
In a truly interoperable ecosystem:
- High-acuity events like stroke should propagate across care settings
- Hospital, outpatient, and professional data should reinforce and not contradict each other
- Validation logic should reflect how care actually happens, not just what gets submitted
When that doesn’t occur, we’re left with:
- Diagnoses detached from expected clinical pathways
- Risk scores built on incomplete longitudinal records
- Compliance models that rely on after-the-fact audits instead of upstream data integrity
The strategic takeaway:
Interoperability isn’t just about access; it’s about contextual integrity.
If a condition as clinically significant as acute stroke can exist in one data stream but not another, it signals a deeper issue:
We’re not fully connecting the story of the patient across the continuum.
As the industry moves toward more prospective, real-time models of risk and value: The winners will be those who don’t just aggregate data, but reconcile it across settings with clinical fidelity.
If this challenge feels familiar, Centauri Health Solutions, Inc can help.
Let’s connect on how to turn fragmented data into clinically aligned, audit-ready insight.”

Stay updated with Hemostasis Today.
-
Jun 2, 2026, 10:55Claudio Laudani: Not All ”Bi-Risk” PCI Patients Are Equal
-
Jun 2, 2026, 10:45Erin VanDyke: Creating a Multidisciplinary Forum Where VTE Remains a Visible Institutional Priority Is What Matters
-
Jun 2, 2026, 10:40Eseosa Ighodaro: A Free Online Stroke Education Series Is Now Live
-
Jun 2, 2026, 10:19Wolfgang Miesbach: Attitudes Towards Gene Therapy for Severe Haemophilia in Germany
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India